Ask Your Colleagues About:

Treatment Strategies
 

switch to the 2 line

Posted: Aug 27, 2008

QUESTION:

In limited resources settings the majority of patients are on NNRTI based HAART. What could be a most appropriate pVL threshold to switch to the 2 line if there is no possibility to do resistance test nor avalible drug for the 3 line.


  

RESPONSE FROM:   

    Thanks for your post.

    While resources differ from location to location, I don't think that the threshold to switch treatments after failure of first line therapy should. Namely, if there is a confirmed and elevated viral load that has no other explanation (ie, non-adherence, concomitant illness), then one should consider switching to an alternative 2nd line regimen.

    Earlier, rather than postponed switching should help reserve the activity of the second-line NRTIs that will be used with protease inhibitor components in 2nd line. In such cases, I would definitely advocate for the use of a ritonavir( Norvir)-boosted PI, since their activity and effectiveness is far greater than unboosted PIs-- a point quite relevant if NRTI activity is potentially compromised.

    Ultimately, we all should continue to strive to get optimal access to medications and diagnostics for all persons with HIV, irrespective of setting.

    BY




Terms of Use: Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body PRO, Body Health Resources Corporation or any sponsor of this forum.

Visitors submitting questions remain solely responsible for the content of their messages. Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care.

powered by ExpertViewpoint